Article Information
vol. 30 no. 162
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 24, 2021
- Accepted August 28, 2021
- Published online November 17, 2021.
Copyright & Usage
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- Robert A. Wise1,
- Mona Bafadhel2,
- Courtney Crim3,18,
- Gerard J. Criner4,
- Nicola C. Day5,
- David M.G. Halpin6,
- MeiLan K. Han7,
- Peter Lange8,9,
- David A. Lipson10,11,
- Fernando J. Martinez12,
- Diego J. Maselli13,
- Dawn Midwinter5,
- Dave Singh14,
- Maeva Zysman15,16,
- Mark T. Dransfield17 and
- Richard E.K. Russell2⇑
- 1Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 2Nuffield Dept of Medicine, University of Oxford, Oxford, UK
- 3Clinical Sciences – Respiratory, GSK, Research Triangle Park, NC, USA
- 4Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
- 5GlaxoSmithKline, GSK House, Brentford, UK
- 6University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK
- 7University of Michigan, Pulmonary & Critical Care, Ann Arbor, MI, USA
- 8Section of Epidemiology, Dept of Public Health, University of Copenhagen, Copenhagen, Denmark
- 9Medical Dept, Herlev and Gentofte Hospital, Herlev, Denmark
- 10Clinical Sciences, GSK, Collegeville, PA, USA
- 11Pulmonary, Allergy and Critical Care Division, Dept of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- 12New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA
- 13Dept of Medicine, University of Texas Health at San Antonio, San Antonio, TX, USA
- 14Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester University NHS Foundation Hospital Trust, Manchester, UK
- 15Service des Maladies Respiratoires, CHU Bordeaux, Pessac, France
- 16Univ-Bordeaux, Centre de Recherche cardio-thoracique de Bordeaux, U1045, CIC 1401, Pessac, France
- 17Division of Pulmonary, Allergy, and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, USA
- 18Affiliation at the time of writing
- Corresponding author: Richard Russell (richard.russell{at}ndm.ox.ac.uk)
Funding
GlaxoSmithKline
Pharmaceutical company funded
Article usage
Altmetrics
Vol 30 Issue 162
Table of Contents
Discordant diagnostic criteria for pneumonia in COPD trials: a review
Jump To
- Article
- Abstract
- Abstract
- Introduction
- Methods
- Differences in pneumonia capture and reporting
- Distinguishing between pneumonia and COPD exacerbations
- Differences in study design and population characteristics
- Towards a standardised definition of pneumonia for COPD clinical trials
- Conclusions
- Supplementary material
- Acknowledgements
- Footnotes
- References
- Figures & Data
- Info & Metrics